US Stock Market Move | Most of the Chinese pharmaceutical stocks rose, BEIGENE (ONC.US) by over 9%
Most Chinese pharmaceutical stocks are up, as of press time, BeiGene's shares surged more than 9%.
On Tuesday, most of the Chinese pharmaceutical stocks rose. As of press time, BeiGene (ONC.US) rose by over 9%, HutchMed (HCM.US) rose by over 4%; and Zai Lab (ZLAB.US) dipped slightly by 0.08%. In terms of news, BeiGene CEO John Oyler mentioned that, according to US Generally Accepted Accounting Principles, the company is expected to achieve a positive operating profit for the full year of 2025 (meaning that operating income will exceed the sum of operating costs, sales expenses, management expenses, and research and development expenses).
Related Articles
US Stock Market Move | Gold and silver mining stocks generally fell, with Hecla Mining Company (HL.US) dropping 3.5%.
US Stock Market Move | YARTEMLEA drug receives FDA approval Omeros Corporation (OMER.US) surges by nearly 65%
US Stock Market Move | The US car safety regulatory agency has launched a defect investigation into the Model 3. Tesla, Inc. (TSLA.US) fell more than 1.4% in the short term.
US Stock Market Move | Gold and silver mining stocks generally fell, with Hecla Mining Company (HL.US) dropping 3.5%.
US Stock Market Move | YARTEMLEA drug receives FDA approval Omeros Corporation (OMER.US) surges by nearly 65%
US Stock Market Move | The US car safety regulatory agency has launched a defect investigation into the Model 3. Tesla, Inc. (TSLA.US) fell more than 1.4% in the short term.
RECOMMEND
